Prosthesis (i.e. – artificial body members) – parts thereof – or ai – Arterial prosthesis – Stent structure
Patent
1994-05-06
1998-12-01
Brittingham, Debra S.
Prosthesis (i.e., artificial body members), parts thereof, or ai
Arterial prosthesis
Stent structure
623 66, A61F 206, A61F 254
Patent
active
058431560
ABSTRACT:
A method for providing a synthetic barrier made of biocompatible polymeric materials in vivo which involves application of a material to a tissue or cellular surface such as the interior surface of a blood vessel, tissue lumen or other hollow space, is disclosed herein. The material may also be applied to tissue contacting surfaces of implantable medical devices. The polymeric materials are characterized by a fluent state which allows application to and, preferably adhesion to, tissue lumen surfaces, which can be increased or altered to a second less fluent state in situ; controlled permeability and degradability; and, in the preferred embodiments, incorporation of bioactive materials for release in vivo, either to the tissue lumen surface or to the interior of the lumen, which alter cell to cell interactions.
REFERENCES:
patent: 2642874 (1953-06-01), Keeling
patent: 2675619 (1954-04-01), Cone
patent: 2677700 (1954-05-01), Jackson et al.
patent: 2854982 (1958-10-01), Pagano
patent: 2979578 (1961-04-01), Curtis
patent: 3036118 (1962-05-01), Jackson et al.
patent: 3535307 (1970-10-01), Moss et al.
patent: 3829506 (1974-08-01), Schmolka et al.
patent: 3868956 (1975-03-01), Alfidi et al.
patent: 3880158 (1975-04-01), Gurney
patent: 3987000 (1976-10-01), Gleichenhagen et al.
patent: 4140126 (1979-02-01), Choudhury
patent: 4156067 (1979-05-01), Gould
patent: 4188373 (1980-02-01), Krezanoski
patent: 4272518 (1981-06-01), Moro et al.
patent: 4377010 (1983-03-01), Fydelor et al.
patent: 4423725 (1984-01-01), Baran et al.
patent: 4445892 (1984-05-01), Hussein et al.
patent: 4448188 (1984-05-01), Loeb
patent: 4459252 (1984-07-01), MacGregor
patent: 4474751 (1984-10-01), Haslam et al.
patent: 4474752 (1984-10-01), Haslam et al.
patent: 4474753 (1984-10-01), Haslam et al.
patent: 4478822 (1984-10-01), Haslam et al.
patent: 4503569 (1985-03-01), Dotter
patent: 4517686 (1985-05-01), Ruoslahti et al.
patent: 4520823 (1985-06-01), LeVeen et al.
patent: 4553545 (1985-11-01), Maass et al.
patent: 4560374 (1985-12-01), Hammerslag et al.
patent: 4573966 (1986-03-01), Weikl et al.
patent: 4578079 (1986-03-01), Ruoslahti et al.
patent: 4580568 (1986-04-01), Glanturco
patent: 4589881 (1986-05-01), Pierschbacher et al.
patent: 4610662 (1986-09-01), Weikl et al.
patent: 4627436 (1986-12-01), Leckrone
patent: 4636195 (1987-01-01), Wolinsky
patent: 4650466 (1987-03-01), Luther
patent: 4655746 (1987-04-01), Daniels et al.
patent: 4655771 (1987-04-01), Wallsten
patent: 4674506 (1987-06-01), Alcond
patent: 4690684 (1987-09-01), McGreevy et al.
patent: 4701509 (1987-10-01), Sun et al.
patent: 4702917 (1987-10-01), Schindler
patent: 4733665 (1988-03-01), Palmaz
patent: 4744366 (1988-05-01), Jang
patent: 4754752 (1988-07-01), Ginsburg et al.
patent: 4763653 (1988-08-01), Rockey
patent: 4763654 (1988-08-01), Jang
patent: 4767619 (1988-08-01), Murray
patent: 4771777 (1988-09-01), Horzewski et al.
patent: 4781677 (1988-11-01), Wilcox
patent: 4799479 (1989-01-01), Spears
patent: 4820298 (1989-04-01), Leveen et al.
patent: 4824436 (1989-04-01), Wolinsky
patent: 4832688 (1989-05-01), Sagae et al.
patent: 4861760 (1989-08-01), Mazuel et al.
patent: 4879135 (1989-11-01), Greco et al.
patent: 4883660 (1989-11-01), Blackman et al.
patent: 4911926 (1990-03-01), Henry et al.
patent: 4938763 (1990-07-01), Dunn et al.
patent: 5041380 (1991-08-01), Ruoslahti et al.
patent: 5059211 (1991-10-01), Stack et al.
patent: 5092841 (1992-03-01), Spears
patent: 5100429 (1992-03-01), Sinofsky et al.
patent: 5120829 (1992-06-01), Pierschbacher et al.
patent: 5126141 (1992-06-01), Henry
patent: 5135751 (1992-08-01), Henry et al.
patent: 5147385 (1992-09-01), Beck et al.
patent: 5149780 (1992-09-01), Plow et al.
patent: 5169930 (1992-12-01), Ruoslahti et al.
patent: 5171217 (1992-12-01), March et al.
patent: 5213580 (1993-05-01), Slepian et al.
patent: 5258042 (1993-11-01), Mehta
patent: 5261878 (1993-11-01), Galindo
patent: 5306249 (1994-04-01), Michel
patent: 5306250 (1994-04-01), March et al.
patent: 5306286 (1994-04-01), Stack et al.
patent: 5328470 (1994-07-01), Nabel et al.
patent: 5399352 (1995-03-01), Hanson
Amaillay, Monique, et al., "The Cellular Interactions of Laminin Fragments," J. Biol. Chem. 262(24):11532-11538 (1987).
Boretos, "Improved Intravascular Delivery of Drug Via a Polyethylene Jet Catheter," The 13th Annual Meeting of the Society of Biomaterials, p. 128.
Clowes, Alexander W., et al., "Kinetics of Cellular Proliferation after Arterial Injury," Laboratory Investigation 49(3):327 (1983).
Clowes, Alexander W., et al., "Kinetics of Cellular Proliferation after Arterial Injury," Laboratory Investigation 52(6):611 (1985).
Clowes, Alexander W. and Stephen M. Schwartz, "Significance of Quiescent Smooth Muscle Migration in the Injured Rat Caro Artery," Circulation Research 56(1)139-145 (Jan. 1985).
Fogerty, Frances J., et al., "Inhibition of Binding of Fibronectin to Matrix Assembly Sites by Anti-Integrin (.alpha., .beta.,) Antibodies," J. Cell Biology, 111:699-708 (1990).
Gahlsan, Kurt R., et al., "Inhibition of In Vitro Tumor Cell Invasion by Arg-Gly-Asp-containing Synthetic Peptides," J. Cell Biol. 106:925-930 (1988).
Ginsberg, Mark H., et al., "Cytoadhesins, Integrins, and Platelets," Thrombosis and Haemostasis 59(1);1-6 (1988).
Greene, T.W., and Wuts, P.G.M., Protective Groups in Organic Synthesis, 2d Ed., John Wiley & Sons, Inc., pp. 317-318 (1991).
Humphrias, Martin J., et al., "A Synthetic Peptide from Fibronactin Inhibits Experimental Matastasis of Murine Melanoma Cells," Science 233:467-470 (Jul. 1986).
Kerenyi, et al., "Local Enzymatic Treatment of Atherosclerotic Plaques," Experimental and Molecular Pathology, vol. 49, pp. 330-338 (1988).
McBride, et al., "Restenosis After Successful Coronary Angioplasty," N. Eng. J. Med., pp. 1734-1737 (1988).
Pierschbacher, Michael and Erkki Runslahti, "Variants of the cell recognition site of fibronactin that retain attachment-promoting activity," Proc. Natl. Sci. 81:5985-5988 (Oct. 1984).
Phillips, David R., et al., The Platelet Membrane Glycoprotein llb-llla Complex, Blood 71(4):831-843 (Apr. 1988).
Ruoslahti, Erkki and Michael D. Pierschbacher, "New Perspectives Cell Adhesion; RGD and Integrins," Science 238:491-497 (Oct. 1987).
Vaheri, Antti, et al., "Codistribution of pericellular matrix proteins in cultured fibroblasts and loss in transformation: Fibronectin and procollagen," Proc. Natl. Acad Sci. 75(10):4944-4948 (Oct. 1978).
"Controlled Release Systems: Fabrication Technology" vol. II, Dean Hsieh, Editor, Chapter 3 Gels for Drug Delivery by David W. Woodford and Dean S. T. Hsieh pp. 42-57 (CRC Press, Florida).
"The Molecular and Cellular Biology of Wound Repair" ed. R.A.F. Clark and P. M. Henson ed., (Plenum Press, NY 1988) Chapter 13. J.B. McCarthy, Sas, and Furcht*.
Aumailley, Monique, "Arg-Gly-Asp constrained within cyclic pentapeptides," FEBS 29(1):50-54 (1991).
Varki, Ajit P., et al., "Identification of a variant of mucolipidosis III (pseudo Hurler polydystrophy); A catalytically active N-acetylglucosaminyl-hosphotransferase that fails to phosphorylate lysosomal enzymes," Proc. Natl. Acad. Sci. USA 78:7773-7777 (1981).
Choi, Eric T., et al., "Inhibition of neointimal hyperplasia by blocking .alpha., .beta..sub.2 integrin with a small peptide antagonist GpenGRGDSPCA," J. Vascular Surgery 125-134 91994).
Greene, T.W., and Wuts, P.G.M., Protective Groups in Organic Synthesis, 2d Ed., John Wiley & Sons, Inc., pp. 317-318 (1991)*.
Gurrath, Marion, et al., "Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides," FEBS 210:911-921 (1992).
Mohri, Hiroshi, et al., "Novel Effect of Cyclicization of the Arg-Gly-Asp-Containing Peptide on Vitronectin Binding to Platelets," American Journal of Hematology 37:14-19 (1991).
Naito, Michitaka, et al., "Vitronectin-Induced Haptotaxis of Vascular Smooth Muscle Cells In Vitro," Experimental Cell Research 194:154-156 (1991).
Pierschbacher and Erkki Ruoslahti, "Influence of Sterochemistry of the Sequence Arg-Gly-Asp-Xaa on Binding Specificity in Cell Adhesion," J. Biol. Chem. 262(36):17294-17298 (1987).
Massia Stephen P.
Slepian Marvin
Brittingham Debra S.
Endoluminal Therapeutics, Inc.
LandOfFree
Local polymeric gel cellular therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Local polymeric gel cellular therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Local polymeric gel cellular therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2392070